SMARCA4 and breast cancer: To verify the PARP1 contribution to the transcription of genes that are concomitantly controlled by BRG1–EP300 complexes (described by Sobczak et al. [12]), we targeted PARP1 with siRNA in both studied breast cancer cell lines and measured the mRNA levels of the selected genes representing two gene ontologies (Figure 3A).